|Table 2: Visual and anatomic outcomes following bevacizumab injection.|
| values were obtained by Student’s -test for continuous variables and chi-square test for dichotomous variables.|
†Percentages were calculated by dividing the area of hemorrhage absorption or change in nonperfusion areas by the area of the circle with a radius of 3600 m.
‡Negative numbers indicate the decrease in the area of nonperfusion during the time period.
Boldface indicates statistical significance ().